Pharmalink Sp. z o.o.
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 3
- Period
- 7 July 2026 – 29 September 2026
Its main clients
Where and what
Supplies · 3
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 11 August 2027 re-tender around February 2027 |
Zakup i dostawa produktu leczniczego Lutetium (177Lu) oksodotreotyd, roztwór do infuzji dla Kliniki Endokrynologii Świętokrzyskiego Centrum Onkologii w Kielcach
Świętokrzyskie Centrum Onkologii Samodzielny Publiczny Zakład Opieki Zdrowotnej w Kielcach |
Urtica sp. z o.o. Pharmalink Sp. z o.o. 1 bid received |
– |
| 14 September 2027 re-tender around March 2027 |
Dostawa materiałów radioizotopowych
Mazowiecki Szpital Wojewódzki im. św. Jana Pawła II w Siedlcach Sp. z o.o. |
Narodowe Centrum Badań Jądrowych Ośrodek Radioizotopów POLATOM Urtica Sp. z o.o. Pharmalink Sp z o.o VOXEL SPÓŁKA AKCYJNA Synektik Pharma Sp. z o.o. Bayer Sp. z o.o. 2 bids received |
– |
| 17 June 2028 re-tender around December 2027 |
91/PN/2026 - Sukcesywna dostawa radiofarmaceutyku: oksodotreotydu lutetu Lu-177 (Lutathera) dla UCK
Uniwersyteckie Centrum Kliniczne |
Urtica Sp. z o.o. Pharmalink sp. z o.o 1 bid received |
– |
Contracts won
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.